Case report: apixaban‐induced thrombocytopenia

Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used...

Descripción completa

Detalles Bibliográficos
Autor principal: Snellgrove, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331230/
https://www.ncbi.nlm.nih.gov/pubmed/28265388
http://dx.doi.org/10.1002/ccr3.809
Descripción
Sumario:Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life‐threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT.

Ejemplares similares